Cytokinesis is the final stage of cell division, in which a single cell is physically separated into two daughter cells. The failure of cytokinesis can lead to aneuploidy, which is often associated with cancer. There is growing evidence that membrane trafficking plays an important role during cytokinesis in animal cells (Albertson et al. 2005; Montagnac et al. 2008) . Although several small GTPases, including ADP-ribosylation factor 6 (ARF6), are known to regulate membrane trafficking during cytokinesis (D'Souza-Schorey & Chavrier 2006; Schweitzer et al. 2011; Schiel & Prekeris 2013) , the mechanisms that control these GTPases spatiotemporally are not well understood. ARF6, like other small GTPases, cycles between an active GTP-bound and an inactive GDP-bound state. Recent studies have shown that ARF6 is crucial for proper cytokinesis, and that it localizes to the midbody, a narrow intercellular bridge connecting two daughter cells (Chesneau et al. 2012; Makyio et al. 2012) .
C-Jun NH 2 -terminal kinase (JNK)/stress-activated protein kinase-associated protein 1 (JSAP1, also known as JIP3 or Sunday Driver) was originally identified as a binding protein for JNK, and was suggested to function as a scaffold in mammalian JNK signaling pathways (Ito et al. 1999; Kelkar et al. 2000) . Subsequent genetic studies supported JSAP1's role as a scaffold protein (Kelkar et al. 2003; Ha et al. 2005 ). In addition, recent studies have indicated that JSAP1 plays key roles in several neuronal processes, including axon elongation and branching (Suzuki et al. 2010; Bilimoria et al. 2010; Sun et al. 2013) . The JNK-associated leucine zipper protein (JLP, also known as JIP4 or SPAG9) is closely related in structure to JSAP1, and can organize JNK and p38 mitogen-activated protein kinase signaling pathways (Lee et al. 2002; Kelkar et al. 2005) . This scaffold protein is reported to be important in myoblast differentiation (Takaesu et al. 2006; Kang et al. 2008) . Jsap1 and Jlp might be paralogous to each other. To date, however, whether JSAP1 and JLP have overlapping functions remains largely unknown.
JSAP1 and JLP have also been identified as kinesin light chain (KLC)-binding proteins, and are thought to function as adaptor proteins that link cargos to kinesin-1 (Verhey et al. 2001; Nguyen et al. 2005) , which is a heterotetramer of two kinesin heavy chains (KHC) and two KLC subunits. KHC includes a globular ATP-binding motor domain. Recently, JSAP1 and JLP were identified as binding partners for active ARF6 (Montagnac et al. 2009; Suzuki et al. 2010) . Montagnac et al. reported that active ARF6 binds to JSAP1/JLP and negatively regulates the association of JSAP1/JLP with kinesin-1. In this study, we investigated the functions of JSAP1 and JLP by gene knockout (KO) and rescue experiments in mouse embryonic fibroblasts (MEFs). Our findings suggest that JSAP1 and JLP play critical, functionally redundant roles in cytokinesis by controlling ARF6's localization to the midbody as part of a tripartite complex of JSAP1/JLP, active ARF6, and kinesin-1.
Results

Phenotypic analysis of Jsap1 KO, Jlp KO, and Jsap1:Jlp double-KO (dKO) MEFs
To examine the roles of JSAP1 and JLP in proliferating cells, we used wild-type and mutant mouse MEFs carrying loxP-flanked (floxed) Jsap1 and/or Jlp alleles, which allow a target gene to be disrupted by an adenovirus vector expressing Cre recombinase (AxCANCre). The disruption of Jsap1 and Jlp by AxCANCre was confirmed by immunoblotting at 24 h post-infection (hpi). JSAP1 and JLP were not detected in AxCANCre-infected Jsap1 f/f or Jlp 2-phenylindole (DAPI) staining at 24, 48, and 72 hpi ( Fig. 1B  and C) . While Cre-induced Jsap1 and Jlp single-KO MEFs grew normally and the number of adherent cells was similar to that in wild-type MEFs at each time point examined, the number of adherent Jsap1:Jlp dKO MEFs was markedly reduced at 48 and 72 hpi, but not at 24 hpi ( Fig. 1B and C) . We next conducted rescue experiments using wild-type and altered forms of JSAP1, including a deletion mutant lacking the KHC-binding domain (KBD) (Sun et al. 2011 ) and a mutant that could not interact with GTP-bound active ARF6 due to substitutions in the leucine zipper domain (Montagnac et al. 2009; Suzuki et al. 2010 , see also Fig. 3 and Fig. S5 in Supporting Information). Lentiviral vectors were used to express these wild-type and mutant JSAP1 forms as hemagglutinin (HA)-tagged proteins (designated HA-JSAP1-WT, -LZ, and -ΔKBD) in the Jsap1:Jlp dKO MEFs. The lentiviral vector-mediated expression of the HA-JSAP1 proteins in dKO MEFs was comparable to that of endogenous Values are the mean + SEM from three independent experiments; n.s., not significant; **P < 0.01; ***P < 0.001; scale bars, 100 µm.
JSAP1 in wild-type MEFs (Fig. 1D) . Although HA-JSAP1-WT almost completely reversed the reduced numbers of dKO MEF cells, neither the HA-JSAP1-LZ nor the ΔKBD mutant was able to rescue the defect (Fig. 1E) . Similar results were obtained with lentiviruses expressing HA-JLP-WT, -LZ, or -ΔKBD ( Fig. S1 in Supporting Information). Taken together, these results suggest that JSAP1 and JLP are functionally redundant and play an important role in cell proliferation through interactions with kinesin-1 and ARF6.
Delayed cytokinesis in Jsap1:Jlp dKO MEFs
While analyzing the MEFs by DAPI staining, we noticed that the proportion of binucleate cells appeared to be higher in the Jsap1:Jlp dKO MEFs than in the wild-type MEFs. We found that the frequency of binucleate cells at 36 hpi was 3 times higher in the dKO MEFs than in wild-type MEFs ( Fig. 2A and B ). This percentage of binucleate cells in the dKO MEFs may actually be underestimated, because many of the dKO MEFs had detached from the plates during culture, and the proportion of adherent dKO MEFs at 36 hpi was around 30% of that in wild-type MEFs (T. Sato and K. Yoshioka, unpublished data). We conducted rescue experiments with lentiviruses expressing HA-JSAP1-WT, -LZ, or -ΔKBD, and HA-JLP-WT, -LZ, or -ΔKBD. As shown in Fig :Jlp f/f MEFs were cultured in the presence of RO-3306, a selective cyclindependent kinase 1 (CDK1) inhibitor (Vassilev et al. 2006) , to arrest the cell cycle at the G 2 /M phase. The inhibitor was released at 24 hpi, and the arrested MEFs were allowed to enter mitosis with a large population of cells at the G 2 /M phase ( Fig. S3 in Supporting Information). Cells in cytokinesis were identified by the presence of the midbody (Fig. 2C ). We found comparable proportions of dKO MEFs and AxCANCre-infected or -uninfected wild-type MEFs in cytokinesis 2 h after releasing the RO-3306 block (Fig. 2D , left). Six hours after release, the percentage of wild-type cells undergoing cytokinesis had severely decreased, whereas many dKO MEFs were still in cytokinesis (Fig. 2D, right) . The lentivirus-mediated expression of HA-JSAP1/JLP-WT, but not of HA-JSAP1/JLP-LZ or -ΔKBD, reversed the increased proportion of cytokinetic cells in the dKO MEFs ( Fig. 2E and Fig. S4 in Supporting Information). Collectively, these results suggest that JSAP1 and JLP regulate cytokinesis through their interactions with kinesin-1 and ARF6, and that the depletion of JSAP1 and JLP delays cytokinesis.
Tripartite complex formation of JSAP1/JLP, ARF6, and kinesin-1 KHC JSAP1 and JLP are known to interact with active ARF6 and KHC. To determine whether JSAP1 forms a tripartite complex with ARF6 and kinesin-1 KHC, we transiently coexpressed HA-JSAP1 (WT, LZ, or KBD) with a Flag-tagged, constitutively active ARF6 mutant (ARF6-Q67L-Flag) and Myc-tagged KHC (Myc-KHC) in human embryonic kidney (HEK) 293T cells. The cell lysates were then immunoprecipitated with an anti-HA antibody (Ab) and analyzed by immunoblotting with an anti-Flag or -Myc Ab (Fig. 3A) . The results showed that HA-JSAP1-WT interacted with both ARF6-Q67L-Flag and Myc-KHC, HA-JSAP1-LZ interacted with Myc-KHC but not ARF6-Q67L-Flag, and HA-JSAP1-KBD interacted with ARF6-Q67L-Flag but not Myc-KHC. Similar results were obtained with HA-JLP-WT, -LZ, and -KBD (Fig. S5A in Supporting Information). We further assessed interactions between ARF6 and KHC in the presence or absence of JSAP1 by co-immunoprecipitation and immunoblotting assays in HEK 293T cells. Although ARF6-Q67L-Flag did not interact with Myc-KHC in the absence of HA-JSAP1-WT (Fig. 3B, lanes 3 and 7) , ARF6- Q67L-Flag and Myc-KHC were detected in precipitates with anti-Myc and -Flag Abs, respectively, in the presence of HA-JSAP1-WT (Fig. 3B, lanes 4 and 8) . Similar results were obtained with HA-JLP-WT (Fig. S5B in Supporting Information). Taken together, these results indicate that JSAP1/JLP, ARF6, and KHC can form a tripartite complex.
Impaired localization of ARF6 to the midbody in Jsap1:Jlp dKO MEFs
ARF6 is known to localize to the midbody during cytokinesis. To test our hypothesis that JSAP1 and JLP are required for targeting ARF6 to the midbody, we compared the localization of endogenous ARF6 in wild-type and dKO MEFs. AxCANCre-infected wild-type and Jsap1 f/f :Jlp f/f MEFs were cultured in the presence of RO-3306. The MEFs were released from the RO-3306 block at 24 hpi, and were stained with an Ab against ARF6 2 h later (Fig. 4) . A large proportion of the acetyl--tubulin-positive intercellular bridges in the wild-type MEFs were stained by the anti-ARF6 Ab. The percentage of intercellular bridges stained for ARF6 was sharply decreased in the dKO MEFs; this decrease was reversed WT, but not of HA-JSAP1/JLP-LZ or -ΔKBD ( Fig.  4B and Fig. S6 in Supporting Information).
We next investigated whether ARF6's localization to the midbody is dependent on its interaction with JSAP1/JLP. ARF6-Q67L-Flag or a variant that could not interact specifically with JSAP1/JLP due to the additional point mutations T53E, K58C, and N60T (Suzuki et al. 2010) , designated ARF6-Q67L-TriM-Flag, was coexpressed with either HA-JSAP1-WT or HA-JLP-WT in HEK 293T cells. We confirmed that HA-JSAP1/JLP-WT interacted with ARF6-Q67L-Flag, but not with ARF6-Q67L-TriM-Flag (Fig.  5A) . We next used lentiviruses to express ARF6-Q67L-Flag and ARF6-Q67L-TriM-Flag in wild-type MEFs, and analyzed the localization of these proteins by immunofluorescence. The vast majority of acetyl--tubulinpositive intercellular bridges in the cells expressing ARF6-Q67L-Flag were Flag-positive, but the frequency of ARF6 localization to the intercellular bridges was severely decreased in cells expressing ARF6-Q67L-TriM-Flag ( Fig.  5B and C) .
Collectively, these results suggest that active ARF6 localizes to the midbody through kinesin-1-dependent interactions with JSAP1/JLP.
Discussion
In the present study, we explored the roles of JSAP1 and JLP in dividing cells. We found that JSAP1 and JLP are functionally redundant, and that the depletion of both proteins causes cytokinesis to fail. We propose that JSAP1 and JLP regulate ARF6's localization to the midbody by forming a tripartite complex of JSAP1/JLP, active ARF6, and kinesin-1 KHC. This proposal is supported by the following lines of evidence: The Jsap1:Jlp dKO MEFs exhibited an increased percentage of binucleate cells and delayed cytokinesis, which were both almost completely rescued by the expression of wild-type JSAP1 or JLP (JSAP1/JLP-WT), whereas JSAP1 or JLP mutants that could not interact with active ARF6 (JSAP1/JLP-LZ) or KHC (JSAP1/JLP-KBD) failed to reverse the defects (Fig. 2 and Figs. S2 and S4 in Supporting Information). In transfected cells, the association of a constitutively active ARF6 mutant (ARF6-Q67L) and KHC was observed only with the co -expression of JSAP1/JLP-WT, but not JSAP1/JLP-LZ or JSAP1/JLP-KBD (Fig. 3 and Fig. S5 in Supporting Information). In addition, the localization of endogenous ARF6 to the midbody was impaired in Jsap1:Jlp dKO MEFs, and this impairment was reversed by the expression of JSAP1/JLP-WT, but not of JSAP1/JLP-LZ or JSAP1/JLP-KBD (Fig. 4 and Fig. S6 in Supporting Information). Finally, in wild-type MEFs, ARF6-Q67L localized to the midbody with high frequency, consistent with previous reports (Schweitzer & D'Souza-Schorey 2002; Makyio et al. 2012) , but this midbody localization was severely impaired by introducing three additional point mutations that prevented ARF6-Q67L's interaction with JSAP1/JLP (Fig. 5) . These data collectively suggest that JSAP1 and JLP function as adaptors that link active ARF6 and kinesin-1.
Our findings are inconsistent with a previous study by Montagnac et al. (2009) , which reported that ARF6-Q67L's binding to JSAP1/JLP interferes with the association of JSAP1/JLP and kinesin-1 KHC. This apparent discrepancy may be explained by the different experimental systems used, and by differences in interpretation of the results. We used a co-immunoprecipitation system in which ARF6-Q67L and KHC were transiently coexpressed with JSAP1/JLP-WT, -LZ, or -KBD in mammalian cells, and then ARF6-Q67L, KHC, and JSAP1/JLP were precipitated and their interactions evaluated by immunoblotting (Fig. 3 and Fig. S5 in Supporting Information). Montagnac et al. used a glutathione S-transferase (GST) pull-down system, in which KHC was pulled down from mammalian cells with a GST fusion protein containing the JLP leucine zipper domain, which is responsible for interactions with KLC and active ARF6, in the presence of ARF6-Q67L. This system pulls KHC down through its interaction with KLC. Montagnac et al. reported that ARF6-Q67L and KLC bind competitively to JSAP1/JLP; they showed that the amount of KHC pulled down decreased as the ARF6-Q67L concentration increased. These results, however, do not necessarily support the proposal that ARF6-Q67L binding to JSAP1/JLP negatively controls the association of JSAP1/JLP with kinesin-1 KHC.
To date, no interaction has been shown between JSAP1/JLP and guanine nucleotide exchange factors (GEFs) for ARF6, which catalyze the transition from the inactive, GDP-bound ARF6 to an active, GTP-bound ARF6. Thus, ARF6 is probably activated independently from JSAP1/JLP, and later forms part of the tripartite complex. It was recently reported that ARF6 is transiently associated with the ingressing cleavage furrow when activated by its GEF EFA6, and is subsequently targeted to the Flemming body, the central region of the midbody, during late cytokinesis (Makyio et al. 2012; Ueda et al. 2013) . JSAP1/JLP might load activated ARF6 at the cleavage furrow and transport it to the midbody in collaboration with kinesin-1. Further study is needed to investigate the spatiotemporal changes of JSAP1 and JLP during cytokinesis.
Materials and Methods
Mice. All experimental procedures involving mice were approved by the Institutional Animal Care and Use Committee of Kanazawa University. Jsap1 f/f mice were generated previously (Iwanaga et al. 2007 ). The generation of mice carrying floxed alleles of Jlp will be described elsewhere in detail. Briefly, two loxP sites were inserted into the intronic regions flanking exon 5 of the Jlp gene. Heterozygous mice (Jlp f/+ ) were crossed with Jsap1 f/+ mice to generate Jsap1 f/+ :Jlp f/+ mice. These mutant mice were backcrossed to C57BL/6 for more than ten generations, and the resulting mice were used in this study. C57BL/6 mice were obtained from Japan SLC (Hamamatsu, Japan).
Cell cultures. MEFs were prepared from 14.5-day-old embryos from wild-type C57BL/6, Jsap1 f/f , Jlp f/f , and Jsap1 f/f :Jlp f/f mice. After removing the heads and internal organs, the embryos were minced, trypsinized, and re-suspended in Dulbecco's modified Eagle's medium (Sigma-Aldrich, St. Louis, MO, USA) containing 10% fetal bovine serum. MEFs were used until passage 5. HEK 293T cells were cultured as described previously (Bayarsaikhan et al. 2007) . In some experiments, RO-3306 (10 µM, Santa Cruz Biotechnology, Santa Cruz, CA, USA) was dissolved in dimethyl sulfoxide (DMSO) and added to the culture medium (see figure  legends) . Plasmids. The mammalian expression plasmid pCL20c-CMV-HA-JSAP1-WT was described previously . The coding sequence for full-length JSAP1 with four leucine-toalanine substitutions (at residues 431, 438, 445, and 452), a deletion mutant of JSAP1 KBD (residues 51-81), full-length mouse JLP (Iwanaga et al. 2008) , full-length JLP with four leucine-to-alanine substitutions (at residues 406, 413, 420, and 427), or a deletion mutant of JLP KBD (residues 45-75), was inserted into pCL20c-CMV-HA to generate pCL20c-CMV-HA-JSAP1-LZ, -JSAP1-KBD, -JLP-WT, -JLP-LZ, and -JLP-KBD, respectively. To generate pCL20c-ARF6-Q67L-Flag and -ARF6-Q67L-TriM-Flag, we subcloned the coding regions of full-length mouse ARF6 (NM_007481) with either one substitution (Q67L) or four substitutions (T53E, K58C, N60T, and Q67L) and a Flag tag sequence at the 3' end into pCL20c-CMV. These coding sequences were also inserted into pcDNA3 (Life Technologies, Carlsbad, CA, USA) to generate the expression plasmids pcDNA3-ARF6-Q67L-Flag and -ARF6-Q67L-TriM-Flag. The coding region for full-length mouse KHC (NM_008449) with a Myc tag sequence at the 5' end was inserted into pcDNA3. The resultant plasmid was designated pcDNA3-Myc-KHC. Substitutions and deletions in cDNAs were introduced by overlapping polymerase chain reaction (PCR), as described previously (Ito et al. 1999) . All PCR products were verified by sequencing.
Viral infection and DAPI-staining analysis. To generate Jsap1 KO, Jlp KO, or Jsap1:Jlp dKO MEFs, the corresponding MEFs were infected with AxCANCre (a gift from I. Saito). For DAPI staining, MEFs were plated in 12-well plates at 5 x 10 3 cells per well and were infected with AxCANCre. The medium containing the virus was removed at 2.5 hpi, and the MEFs were washed twice with fresh medium and then cultured in fresh medium. At 24, 48, and 72 hpi, the MEFs were washed once with phosphatebuffered saline, fixed with 4% paraformaldehyde, and stained with DAPI (Sigma-Aldrich). DAPI-positive cells in five randomly chosen fields (1.4 mm 2 per field) were counted for each experiment. Images were captured with a fluorescence microscope (Olympus IX71, Olympus, Tokyo, Japan). The pCL20c series of lentiviral vectors was produced as described previously . MEFs were infected with the lentiviruses at least three days before AxCANCre infection, and were used for rescue experiments.
Flow cytometry. MEFs were plated in 9-cm dishes at 1 x 10 5 cells per dish, and were cultured in the presence of either DMSO (vehicle) or RO-3306. MEFs were harvested after 22 h, and were fixed with 70% ethanol, treated with RNase A (Sigma-Aldrich), stained with propidium iodide (Sigma-Aldrich), and analyzed by a flow cytometer (FACSCanto II, BD Biosciences, San Jose, CA, USA). Transfection, immunoprecipitation and immunoblotting. HEK 293T cells were plated in 35-mm dishes at 2 x 10 5 cells per dish, and were co-transfected with expression plasmids using polyethylenimine, essentially as described previously (Tanahashi et al. 2010) . Twenty-four hours after transfection, the cells were lysed in lysis buffer (25 mM Tris-HCl pH 7.5, 1 mM EDTA, 5 mM MgCl 2 , 10 mM KCl, and 1% TritonX-100) containing Protease Inhibitor Cocktail (Sigma-Aldrich), and were analyzed by immunoblotting as described previously (Sato et al. 2004 ) using the following Abs: rabbit polyclonal anti-JSAP1 (0.33 µg/ml; Miura et al. 2006) , rabbit polyclonal anti-JLP (2 µg/ml; Iwanaga et al. 2008) , rat polyclonal anti-HA (1:5000; Roche, Basel, Switzerland), mouse monoclonal horseradish peroxidase (HRP)-conjugated anti-Flag M2 (1:1000; Sigma-Aldrich), mouse monoclonal anti-Myc (1:3000; Cell Signaling Technology, Beverly, MA, USA), and rabbit polyclonal anti-actin (1:1000; Sigma-Aldrich). The following secondary HRPconjugated IgG Abs were used: sheep anti-mouse and donkey antirabbit (1:5000, both from GE Healthcare, Buckinghamshire, UK), and goat anti-rat (1:5000, Santa Cruz Biotechnology). Protein bands were visualized using the Immobilon Western Chemiluminescence system (Millipore, Bedford, MA, USA) . To analyze protein-protein interactions, cell lysates (prepared as described above) were immunoprecipitated with rat polyclonal anti-HA (1:500; Roche), mouse monoclonal anti-Flag M2 (1:1000; Sigma-Aldrich), or mouse monoclonal anti-Myc (1:1000; Cell Signaling Technology) Abs bound to protein G-Sepharose (GE Healthcare) beads, and were analyzed by immunoblotting.
Immunocytochemistry. For immunocytochemical analysis, MEFs were plated onto glass cover slips (Thermo Fisher Scientific To analyze ARF6's localization during cytokinesis, MEFs were cultured in the presence of RO-3306, fixed 2 h after the RO-3306 blockade was released, and immunostained with rabbit monoclonal anti-acetyl--tubulin (1:1500; Cell Signaling) and either mouse monoclonal anti-ARF6 (1:100; Santa Cruz Biotechnology) or mouse monoclonal anti-Flag M2 (1:2000; Sigma-Aldrich) Abs. The secondary Abs used were goat Alexa fluor 488-conjugated anti-mouse IgG and goat Alexa fluor 568-conjugated anti-rabbit IgG Abs (both diluted 1:1000; Life Technologies). Immunocytochemistry was performed by standard protocols as described previously (Sato et al. 2011) . Images were captured with a confocal laser scanning microscope (LSM510; Zeiss, Oberkochem, Germany).
Statistical analysis. Significance was determined using a two-tailed unpaired Student's t-test. P < 0.05 was considered to be statistically significant. Supporting Information Figure S1 . MEFs infected with lentiviruses expressing the indicated HA-JLPs were further infected with AxCANCre, and were cultured in the presence of RO-3306. Cytokinetic cells were counted 6 h after the MEFs were released from RO-3306, and were quantified as in Fig. 2D . In each experiment, 200-400 cells were counted. Values are the mean + SEM from three independent experiments; n.s., not significant; *P < 0.05; ***P < 0.001. Fig. 4B . Twenty intercellular bridges were analyzed per experiment. Values are the mean + SEM from three independent experiments; n.s., not significant; ***P < 0.001.
